Results 191 to 200 of about 86,801 (271)

Inflammation, Immunity, and Cardiovascular Diseases

open access: yesMed Research, Volume 2, Issue 2, Page 343-370, June 2026.
Cardiovascular stress signals (e.g., hemodynamic shear, oxidized lipids, and ischemia) act on endothelial and immune cells to activate and amplify inflammation through NF‐κB, the NLRP3 inflammasome, and JAK/STAT signaling, inducing proinflammatory cytokines/chemokines (IL‐6, IL‐1β, TNF‐α, and CCL2) and self‐amplifying circuits; clinically, inflammatory
Dezhi Guo   +8 more
wiley   +1 more source

Bilateral sceletonized internal mammary arteries for myocardial revascularization in elderly patients. [PDF]

open access: yesJ Geriatr Cardiol
Jonjev ŽS   +5 more
europepmc   +1 more source

PTEN in the Context of Myocardial Revascularization: The Iceberg Tip? [PDF]

open access: yesArq Bras Cardiol, 2023
Garcia LR   +3 more
europepmc   +1 more source

Development and Validation of a Nomogram Incorporating Preoperative N‐Terminal Pro‐Brain Natriuretic Peptide to Predict Major Adverse Cardiovascular Events in Renal Transplant Recipients

open access: yesOrgan Medicine, Volume 3, Issue 2, Page 63-75, June 2026.
We developed and validated a preoperative nomogram incorporating NT‐proBNP to predict major adverse cardiovascular events in renal transplant recipients. Using a LASSO‐Cox model based on 582 training and 181 validation cases, we identified NT‐proBNP, age, body mass index, diabetes, and retransplantation as key predictors.
Guobin Wu   +9 more
wiley   +1 more source

Optimal medical care and coronary flow capacity-guided myocardial revascularization vs usual care for chronic coronary artery disease: the CENTURY trial. [PDF]

open access: yesEur Heart J
Gould KL   +14 more
europepmc   +1 more source

Surgical myocardial revascularization outcomes in Kawasaki disease: systematic review and meta-analysis. [PDF]

open access: yesOpen Med (Wars), 2021
Salsano A   +6 more
europepmc   +1 more source

Myocardial revascularization

open access: yesThe Journal of Thoracic and Cardiovascular Surgery, 1976
Jorge Oglietti   +3 more
openaire   +1 more source

Meta Analysis of DHA and EPA Supplementation on Cardiovascular Outcomes and Atrial Fibrillation Risk

open access: yesPharmacology Research &Perspectives, Volume 14, Issue 3, June 2026.
ABSTRACT Cardiovascular diseases (CVD) remain to impose a main global burden of morbidity and mortality despite advances in anticipation and treatment. Omega‐3 fatty acids, mainly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), have been extensively studied for potential cardioprotective effects, yet their impact on cardiovascular outcomes ...
Sepideh Karkon Shayan   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy